Charles Schwab
STTK icon

Charles Schwab’s Shattuck Labs STTK Stock Holding History

Charles Schwab’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Buy
189,899
+149,018
+365% +$929K ﹤0.01% 2918
2026
Q1 		$263K Buy
40,881
+20,000
+96% +$94.9K ﹤0.01% 3269
2025
Q4 		$76.2K Hold
20,881
– – ﹤0.01% 3409
2025
Q3 		$49.9K Sell
20,881
-25
-0.1% -$31 ﹤0.01% 3431
2025
Q2 		$16.6K Sell
20,906
-93,233
-82% -$90.4K ﹤0.01% 3492
2025
Q1 		$108K Hold
114,139
– – ﹤0.01% 3333
2024
Q4 		$138K Hold
114,139
– – ﹤0.01% 3371
2024
Q3 		$398K Sell
114,139
-6,820
-6% -$25.4K ﹤0.01% 3216
2024
Q2 		$467K Buy
120,959
+100,078
+479% +$814K ﹤0.01% 3226
2024
Q1 		$187K Hold
20,881
– – ﹤0.01% 3246
2023
Q4 		$149K Hold
20,881
– – ﹤0.01% 3310
2023
Q3 		$31.7K Hold
20,881
– – ﹤0.01% 3458
2023
Q2 		$65.1K Hold
20,881
– – ﹤0.01% 3384
2023
Q1 		$61.4K Hold
20,881
– – ﹤0.01% 3313
2022
Q4 		$48K Hold
20,881
– – ﹤0.01% 3370
2022
Q3 		$57K Sell
20,881
-108,786
-84% -$408K ﹤0.01% 3300
2022
Q2 		$527K Sell
129,667
-59,717
-32% -$216K ﹤0.01% 3055
2022
Q1 		$807K Sell
189,384
-6,992
-4% -$39.7K ﹤0.01% 2935
2021
Q4 		$1.67M Buy
196,376
+2,559
+1% +$35.3K ﹤0.01% 2757
2021
Q3 		$3.95M Buy
193,817
+78,208
+68% +$1.67M ﹤0.01% 2475
2021
Q2 		$3.35M Buy
115,609
+28,387
+33% +$830K ﹤0.01% 2547
2021
Q1 		$2.55M Buy
87,222
+3,210
+4% +$135K ﹤0.01% 2599
2020
Q4 		$4.4M Buy
+84,012
New +$2.7M ﹤0.01% 2283

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab's STTK Position: Q2 2026 in Review

Charles Schwab increased its Shattuck Labs (STTK) stake by 365% in Q2 2026, buying an estimated $929K and bringing the position to 189,899 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2918.

Charles Schwab first reported a position in STTK in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.4M in Q4 2020. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • Charles Schwab held 189,899 shares of Shattuck Labs worth $1.32M as of Q2 2026.
  • Charles Schwab bought 149,018 Shattuck Labs shares in Q2 2026, an estimated $929K.
  • Shattuck Labs made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2918 holding.
  • Charles Schwab first reported a position in Shattuck Labs in Q4 2020 and has held it in 23 quarters since.
  • Charles Schwab's Shattuck Labs position peaked at $4.4M in Q4 2020.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.